<DOC>
	<DOC>NCT02087306</DOC>
	<brief_summary>This is a multicenter study of Brincidofovir (CMX001) (BCV) administered twice weekly (BIW) for the treatment of AdV infection detected during asymptomatic AdV viremia or during symptomatic AdV infection. After completing a screening assessment to confirm study eligibility, all enrolled subjects will undergo a treatment period of 12 weeks. Beginning on Day 1, adult (â‰¥ 18 years) and adolescent (13-17 years) subjects weighing &gt; 50 kg will receive BCV 100 mg BIW; children up to 12 years of age will receive weight-based doses of 2 mg/kg BIW, not-to-exceed a total dose of 200 mg/week.</brief_summary>
	<brief_title>Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Adenoviridae Infections</mesh_term>
	<criteria>Patients who have undergone hematopoietic cell transplant (HCT), solid organ transplant (SOT) Have a primary or other severe immunodeficiency which predisposes to rapid progression to disseminated AdV disease Must be able to ingest, absorb and tolerate oral medication Willing and able to understand and provide written informed consent. For minors or those incapable of providing written informed consent (i.e., incapacitated), understood, written and informed consent must be provided by a parent or legal guardian or representative. To the best of his or her (or parent/guardian) knowledge, willing and able to participate in all required study activities for the duration of the study. Females who are pregnant or currently nursing. Patients with any other condition that would, in the judgment of the investigator, put the patient at increased risk during participation in the study, or interfere with the conduct of the study.</criteria>
	<gender>All</gender>
	<minimum_age>2 Months</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Adenovirus Infection</keyword>
</DOC>